JP2009529559A - 耳鳴り治療用製剤 - Google Patents

耳鳴り治療用製剤 Download PDF

Info

Publication number
JP2009529559A
JP2009529559A JP2008558724A JP2008558724A JP2009529559A JP 2009529559 A JP2009529559 A JP 2009529559A JP 2008558724 A JP2008558724 A JP 2008558724A JP 2008558724 A JP2008558724 A JP 2008558724A JP 2009529559 A JP2009529559 A JP 2009529559A
Authority
JP
Japan
Prior art keywords
vitamin
tinnitus
magnesium
use according
dosage unit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008558724A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009529559A5 (enExample
Inventor
ウーヴェ・ストールド
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2009529559A publication Critical patent/JP2009529559A/ja
Publication of JP2009529559A5 publication Critical patent/JP2009529559A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Packages (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2008558724A 2006-03-15 2007-03-15 耳鳴り治療用製剤 Pending JP2009529559A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006011922A DE102006011922A1 (de) 2006-03-15 2006-03-15 Mittel zur Behandlung von Tinnitus
PCT/EP2007/002294 WO2007104566A1 (de) 2006-03-15 2007-03-15 Mittel zur behandlung von tinnitus

Publications (2)

Publication Number Publication Date
JP2009529559A true JP2009529559A (ja) 2009-08-20
JP2009529559A5 JP2009529559A5 (enExample) 2010-06-24

Family

ID=38229816

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008558724A Pending JP2009529559A (ja) 2006-03-15 2007-03-15 耳鳴り治療用製剤

Country Status (9)

Country Link
US (2) US20090220592A1 (enExample)
EP (1) EP1993578A1 (enExample)
JP (1) JP2009529559A (enExample)
AU (1) AU2007224668A1 (enExample)
CA (1) CA2646528A1 (enExample)
DE (1) DE102006011922A1 (enExample)
EA (1) EA013457B1 (enExample)
IL (1) IL194066A0 (enExample)
WO (1) WO2007104566A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201010691A (en) * 2008-06-12 2010-03-16 Merz Pharma Gmbh & Co Kgaa 1-amino-alkylcyclohexane derivatives for the treatment of sleep disorders
AU2019240293A1 (en) * 2018-03-23 2020-10-15 Vanessa Research, Inc. Compositions and methods for treating diarrheal diseases
KR102175201B1 (ko) * 2019-09-06 2020-11-06 (주)아이엠디팜 빌베리 추출물을 유효성분으로 함유하는 감각신경성 난청 예방 또는 치료용 조성물
EP4299059A1 (en) 2022-07-01 2024-01-03 Labelic Analysis, S.L. Composition for the treatment of tinnitus

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002308752A (ja) * 2001-04-06 2002-10-23 Nikko Chemical Co Ltd 皮膚外用剤
DE202004004618U1 (de) * 2004-03-24 2004-05-19 Aiones The Brainpower Company Blaubeerextrakt
JP2005306882A (ja) * 2005-06-08 2005-11-04 Alan Smith Richard 感情的不安定の治療のための医薬の製造に有用な組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103756A (en) * 1999-08-11 2000-08-15 Vitacost Inc. Ocular orally ingested composition for prevention and treatment of individuals
US6524619B2 (en) * 2000-01-27 2003-02-25 Chronorx, Inc. Dosage forms useful for modifying conditions and functions associated with hearing loss and/or tinnitus
WO2005092330A1 (de) * 2004-03-24 2005-10-06 Aiones The Brainpower Company Arzneimittel oder diätetikum zur oralen verabreichung enthaltend blaubeerextrakt sowie antioxidatien und mikronährstoffe

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002308752A (ja) * 2001-04-06 2002-10-23 Nikko Chemical Co Ltd 皮膚外用剤
DE202004004618U1 (de) * 2004-03-24 2004-05-19 Aiones The Brainpower Company Blaubeerextrakt
JP2005306882A (ja) * 2005-06-08 2005-11-04 Alan Smith Richard 感情的不安定の治療のための医薬の製造に有用な組成物

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN6012038473; 荒木五郎: '特集-頭痛・めまい・耳鳴り　頭痛をきたす疾患　片頭痛・頭痛症' 月刊臨床と研究 Ｖｏｌ．７０，Ｎｏ．６, 1993, Ｐａｇｅ．１７３１-１７３６ *

Also Published As

Publication number Publication date
WO2007104566A1 (de) 2007-09-20
IL194066A0 (en) 2009-09-22
US20090220592A1 (en) 2009-09-03
EP1993578A1 (de) 2008-11-26
AU2007224668A1 (en) 2007-09-20
CA2646528A1 (en) 2007-09-20
EA013457B1 (ru) 2010-04-30
US20110280972A1 (en) 2011-11-17
EA200801890A1 (ru) 2009-04-28
DE102006011922A1 (de) 2007-09-20

Similar Documents

Publication Publication Date Title
US6793942B2 (en) Composition and method for treating the effects of diseases and maladies
EP0913155B1 (en) Pharmaceutical formulation for treating liver disorders
US6841544B2 (en) Composition and method for treating the effects of diseases and maladies
US6576267B2 (en) Composition and method for treating the effects of diseases and maladies
US6787164B2 (en) Composition and method for treating the effects of diseases and maladies
US6759062B2 (en) Composition and method for treating the effects of diseases and maladies
WO1995017889A1 (en) Therapeutic composition for hyperparathyroidism of patient subjected to artificial dialysis
US8557310B2 (en) Composition to retard the onset of symptoms of alzheimer's disease
US20110280972A1 (en) Preparation for the treatment of tinnitus
US20200254039A1 (en) Pharmaceutical compositions containing cannabis, uses thereof and methods for improving sleep quality
US10238707B2 (en) Composition for the prevention and/or treatment of allergy symptoms
US5397573A (en) Laxative compositions
JP4819869B2 (ja) 難治性掻痒の痒み並びに炎症を抑制・緩和するための薬剤
US20020034555A1 (en) Composition and method for treating the effects of diseases and maladies
EP3362047A2 (en) Low dose oral dipyridamole compositions and uses thereof
JP2002360220A (ja) 血行障害の改善作用を有する健康補助食品
JP5106809B2 (ja) ラクトフェリンを含有する医薬組成物ならびに加工食品
JP7074388B1 (ja) 鼻用の外用剤
KR0155976B1 (ko) 항스트레스 의약조성물
CN114617916A (zh) 一种枇杷叶提取物及其在康养方面中的应用
DE202004004618U1 (de) Blaubeerextrakt
WO2005092330A1 (de) Arzneimittel oder diätetikum zur oralen verabreichung enthaltend blaubeerextrakt sowie antioxidatien und mikronährstoffe
Setiawati et al. The efficacy of Rhinos® SR on nasal resistance and nasal symptoms in patients with perennial allergic rhinitis: a randomized, double-blind, placebo-controlled study
WO2022243525A1 (en) Synergistic effects on weight loss, improved quality of life and gastro-intestinal side effects with a composition of orlistat and acarbose
US20190314327A1 (en) Pharmaceutical Compositions Containing Cannabis, Uses Thereof and Methods for Improving Digestion and/or Treating Symptoms Associated with Gastrointestinal Complications

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100315

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100510

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120724

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20130125